Comparative aspects of diabetes mellitus in dogs and cats

Molecular and Cellular Endocrinology

Volumn 197, Issue 1-2, 2002, Pages 221-229

  Hoenig, M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Glucagon; Glucose; Insulin; Leptin; Lipids

Indexed keywords

INSULIN; FATTY ACID; GLUCOSE; TRIACYLGLYCEROL;

CAT; CLINICAL FEATURE; DIABETES MELLITUS; DIABETOGENESIS; DISEASE CLASSIFICATION; DOG; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPECIES COMPARISON; ANIMAL; ANIMAL DISEASE; BLOOD; BODY WEIGHT; CAT DISEASE; COMPARATIVE STUDY; DOG DISEASE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; BODY WEIGHT; CAT DISEASES; CATS; DIABETES MELLITUS; DOG DISEASES; DOGS; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HUMANS; INSULIN; TRIGLYCERIDES;

EID: 0037195511     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00264-2     Document Type: Review

References (62)

1. Atkins C.E., Chin H.P. Insulin kinetics in juvenile canine diabetics after glucose loading. Am. J. Vet. Res. 44:1983;596-600.
2. Atkins C.E., Hill J.R., Johnson R.K. Diabetes mellitus in the juvenile dog: a report of 4 cases. J. Am. Vet. Med. Assoc. 175:1979;362-368.
3. Baekkeskov S., Nielsen J.H., Marner B., Bilde T., Ludvigsson J., Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature. 298:1982;167-169.
4. Baekkeskov S., Aanstoot H.-K., Christgau S. Identification of the 64 k autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 347:1990;151-156.
5. Bennett N., Greco D.S., Peterson M.E. Comparison of a low carbohydrate diet versus high fiber diet in cats with diabetes mellitus. 19th Annual ACVIM Forum, Abstract 103 J. Vet. Int. Med. 15:2001;297.
6. Berk P.D., Zhou S.-L., Kiang C.-L., Stump D., Bradbury M., Isola L.M. Uptake of long chain free fatty acids is selectively up-regulated in adipocytes of Zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus. J. Biol. Chem. 272:1997;8830-8835.
7. Bradshaw J.W.S., Goodwin D., Legrad-Defretin V., Nott H.M.R. Food selection by the domestic cat, an obligate carnivore. Comp. Biochem. Physiol. 114:1996;205-209.
8. Campbell J., Pierluissi J., Kovacs K. Pancreatic islet ultrastrucutre, serum and pancreatic insulin in somatotrophic and pancreatic immunoreactive insulin in somatotrophic and metasomatotrophic diabetes in dogs. J. Submicrosc. Cytol. 13:1981;599-608.
9. Eigenmann J.E., Eigenmann R.Y., Rijnberk A., Van der Gaag I., Zapf J., Froesch E.R. Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes mellitus and acromegaly. Acta Endocrinol. 104:1983;167-176.
10. Eizirik D.L., Darville M.I. Beta-cell apoptosis and defense mechanisms: lessons from type 1 diabetes. Diabetes. 50:2001;S64-69.
11. Foulis A.K., Stewart J.A. The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia. 26:1984;456-461.
12. Frank, G., Anderson, W., Pazak, H., Hodkins, E., Ballam, J., Laflamme, D. Use of a high protein diet in the management of feline diabetes mellitus. Vet. Therapeutics, in press.
13. Gautier J.-F., Wilson C., Weyer C., Mott D., Knowler W.C., Cavaghan M., Polonsky K.S., Bogardus C., Pratley R.E. Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. Diabetes. 50:2001;1828-1833.
14. Gepts W., Youssaint D. Spontaneous diabetes in dogs and cats. A pathological study. Diabetologia. 3:1967;249-265.
15. Gerich J.E. Addressing the insulin secretion defect: a logical first-line approach. Metabolism. 49:2000;12-16.
16. Gorus F.K., Goubert P., Semakula C. IA-2-auto-antibodies complement GAD-65-autoantibodies in new-on-set IDDM patients and help predict impending diabetes in their siblings. Diabetologia. 40:1997;95-99.
17. Guiot Y., Sempoux C., Moulin P., Rahier J. No decrease of the beta-cell mass in type 2 diabetic patients. Diabetes. 50:(Suppl. 1):2001;S188.
18. Hall D.G., Kelley L.C., Gray M.L., Glaus T.M. Lymphocytic inflammation of pancreatic islets in a diabetic cat. J. Vet. Diagn. Invest. 9:1997;98-100.
19. Hamaguchi T., Fukushima H., Uehara M., Wada S., Shirotani T., Kishikawa H., Ichinose K., Yamaguchi K., Shichiri M. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells. Diabetologia. 34:1991;801-806.
20. Hess R.S., Saunders H.M., Van Winkle T.J., Ward C.R. Concurrent disorders in dogs with diabetes mellitus: 221 cases (1993-1998). J. Am. Vet. Med. Assoc. 217:2000;1166-1173.
21. Hoenig M., Dawe D.L. A qualitative assay for beta cell antibodies. Preliminary results in dogs with diabetes mellitus. Vet. Immunol. Immunopathol. 32:1992;195-203.
22. Hoenig M., 2000a. Obesity in the cat. Proceedings of 18th ACVIM, pp. 662-663.
23. Hoenig M., Hall G., Ferguson D., Jordan J., Henson M., Johnson K., O'Brien T.D. A feline model of experimentally induced islet amyloidosis. Am. J. Pathol. 157:2000a;2143-2150.
24. Hoenig M., Reusch C., Peterson M.E. Beta cell and insulin antibodies in treated and untreated diabetic cats. Vet. Immunol. Immunopathol. 77:2000b;93-102.
25. Hoenig, M., Alexander, S., Pazak, H., 2000c. Effect of a high and low protein diet on glucose metabolism and lipids in the cat. Proceedings, Purina Nutrition Forum, St. Louis, p. 159.
26. Hoenig M., Alexander S., Holson J., Ferguson D.C. Influence of glucose dosage on interpretation of intravenous glucose tolerance tests in lean and obese cats. J. Vet. Int. Med. 16:2002;32-40.
27. Imagawa A., Hanafusa T., Tamura S., Morikawi M., Itoh N., Yamamoto K., Iwahashi H., Yamagata K., Waguri M., Nanmo T., Uno S., Nakajima H., Namba M., Kawata S., Miyagawa J.L., Matsuzawa Y. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes. 50:2001;1269-1273.
28. Kaiyala K.J., Prigeon R.L., Kahn S.E., Woods S.C., Porte D. Jr., Schwartz M.W. Reduced beta-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding. Am. J. Physiol. 277:1999;E659-E667.
29. Kirk C.A., Feldman E.C., Nelson R.W. Diagnosis of naturally acquired type-I and type-II diabetes mellitus in cats. Am. J. Vet. Res. 54:1993;463-467.
30. Kooistra H.S., den Hertog E., Okkens A.C., Mol J.A., Rijnberk A. Pulsatile secretion pattern of growth hormone during the luteal phase and mid-anoestrus in beagle bitches. J. Reprod. Fertil. 119:2000;217-222.
31. Kramer J.W., Nottingham S., Robinette J. Inherited, early onset, insulin-requiring diabetes mellitus of keeshond dogs. Diabetes. 29:1980;558-565.
32. Kukreja A., Maclaren N.K. Atoimmunity and diabetes. J. Clin. Endocrinol. Metab. 84:1999;4371-4378.
33. Lendrum R., Walker G., Cudworth A.G. Islet cell antibodies in diabetes mellitus. Lancet. 2:1976;1273-1276.
34. Lukens F.D.W., Dohan F.C. Pituitary-diabetes in the cat. Recovery following insulin or dietary therapy. Endocrinology. 30:1942;175-201.
35. Lutz T.A., Aisncow J., Rand J.S. Frequency of pancreatic amyloid deposition in cats from south-eastern Queensland. Austr. Vet. J. 71:1994;254-256.
36. Mandrup-Poulsen T. Beta-cell apoptosis: stimuli and signaling. Diabetes. 50:2001;S58-S63.
37. Mattheeuws D., Rottiers R., Baeyens D., Vermeulen A. Glucose tolerance and insulin response in obese dogs. J. Amer. Anim. Hosp. Assoc. 20:1982;287-293.
38. Mattheeuws D., Rottiers R., Kaneko J.J., Vermeulen A. Diabetes mellitus in dogs: relationship of obesity to glucose tolerance and insulin response. Am. J. Vet. Res. 45:1984;98-103.
39. Minkus G., Reusch C., Hänichen T., Colbatzky F., Hermann W. Pathologische Veränderungen des endokrinen Pankreas bei Hund und Katze im Vergleich mit klinischen Daten. Tierärztl. Praxis. 19:1991;282-289.
40. Mirel R.D., Ginsberg-Fellner F., Horwitz D.L., Rayfield E.J. C-peptide reserve in insulin dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide. Diabetologia. 19:1980;183-188.
41. Montgomery T.M., Nelson R.W., Feldman E.C., Robertson K., Polonsky K.S. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism. J. Vet. Int. Med. 10:1996;116-122.
42. Marmor M., Willeberg P., Glickman L.T., Priester W.A., Cypess R.H., Hurvitz A.I. Epizootiologic pattern of diabetes mellitus in dogs. Am. J. Vet. Res. 43:1982;465-470.
43. Nelson R.W., Griffey S.M., Feldman E.C., Ford S.L. Transient clinical diabetes mellitus in cats: 10 cases (1989-1991). J. Vet. Int. Med. 13:1999;28-35.
44. O'Brien T.D., Hayden D.W., Johnson K.H., Stevens J.B. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis. Vet. Pathol. 22:1985;250-261.
45. Palmer J.P., Asplin C.M., Clemons P. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 222:1983;1337-1339.
46. Panciera D.L., Thomas C.B., Eicker S.W., Atkins C.E. Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986). J. Am. Vet. Med. Assoc. 197:1990;1504-1508.
47. Peterson M.E. Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism. Res. Vet. Sci. 36:1984;177-182.
48. Peterson M.E., Nesbitt G.H., Schaer M. Diagnosis and management of concurrent diabetes mellitus and hyperadrenocorticism in thirty dogs. J. Am. Vet. Med. Assoc. 178:1981;66-69.
49. Porte D. Jr. β-cells in type II diabetes mellitus. Diabetes. 40:1991;166-180.
50. Root M.V., Johnson K.H., Allen W.T., Johnston S.D. Diabetes mellitus associated with pancreatic endocrine insufficiency in a kitten. J. Small Anim. Pract. 36:1995;416-420.
51. Scarlett J.M., Donoghue S. Associations between body condition and disease in cats. J. Am.Vet. Med. Assoc. 212:1998;1725-1731.
52. Selman P.J., Mol J.A., Rutteman G.R., van Garderen E., Rijnberk A. Progestin-induced growth hormone excess in the dogs originates in the mammary gland. Endocrinology. 134:1994;287-292.
53. Sempoux C., Guiot Y., Dubois D., Moulin P., Rahier J. Human type 2 diabetes: morphological evidence for abnormal beta-cell function. Diabetes. 50:(Suppl. 1):2001;S172-S177.
54. Shimabukuro M., Zhou Y.T., Levi M., Unger R.H. Fatty-acid induced beta cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. USA. 95:1998;2498-2502.
55. Standridge M., Alemzahdeh R., Zemel M., Koontz J., Moustaid-Moussa N. Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats. FASEB. 14:2000;455-460.
56. Taniyama H., Hirayama K., Kagawa T., Tajima M., Yoshin T., Furuoka H. Histopathological and immunohistochemical analysis of the endocrine and exocrine pancreas in twelve cattle with insulin-dependent diabetes mellitus (IDDM). J. Vet. Med. Sci. 61:1999;803-810.
57. Unger R.H., Zhou Y.T., Orci L. Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc. Natl. Acad. Sci. USA. 96:1999;2327-2332.
58. van Keulen L.J., Wesdorp J.L., Kooistra H.S. Diabetes mellitus in a dog with a growth hormone-producing acidophilic adenoma of the adenohypophysis. Vet. Pathol. 33:1996;451-453.
59. Verge C.F., Gianini R., Kawasaki E. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bcd/IA-2 autoantibodies. Diabetes. 45:1996;926-933.
60. Westermark P., Wilander E. The influence of amyloid deposits on islet volume in maturity onset diabetes mellitus. Diabetologia. 15:1978;417-421.
61. Woods J.P., Panciera D.L., Snyder P.S., Jackson M.W., Smedes S.L. Diabetes mellitus in a kitten. J. Am. Anim. Hosp. Assoc. 30:1994;177-180.
62. Yano B.L., Hayden D.W., Johnson K.H. Feline insular amyloid: association with diabetes mellitus. Vet. Pathol. 18:1981;621-627.